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ABSTRACT
Introduction: Long-term outcome of patients following
conversion during laparoscopic surgery for colorectal can-
cer is not often reported. Recent data suggest a negative
impact of conversion on long-term survival. This study
aimed to evaluate the impact of conversion on the peri-
operative outcome and on long-term survival in patients
who underwent laparoscopic resection for curable colo-
rectal cancer.
Methods: Evaluation of our prospective in-hospital col-
lected data of patients who underwent laparoscopic sur-
gery for curable colorectal cancer over a 5-year period.
Long-term data were collected from our outpatient’s clinic
data and personal contact when necessary.
Results: During the study period, 175 patients were op-
erated on laparoscopically for curable colon cancer (stage
I-III). Mean follow-up was 3318 months with a mini-
mum follow-up of 12 months. For various reasons, 25
patients (14.4%) had to be converted to open surgery.
Short-term outcome revealed a trend towards longer op-
erations, a higher rate of surgical complications, and a
longer hospital stay in the converted group. Five-year,
Kaplan-Meier, disease-free analysis was worse for con-
verted patients. Overall survival did not differ between the
2 groups. Cox proportional hazards regression analysis
revealed that conversion and AJCC stage were indepen-
dent risk factors for recurrence.
Conclusions: Conversion in laparoscopic surgery for cur-
able colorectal cancer is associated with a worse periop-
erative outcome and worse disease-free survival.
Key Words: Colorectal cancer, Conversion, Laparoscopy,
Survival.
INTRODUCTION
Carcinoma of the colon and rectum is the third most
common cancer in North America with an estimated
142 000 new cancer cases and 51 000 cancer-related
deaths in United States in 2010.1
The prognosis of patients with colorectal cancer (CRC) is
largely related to the stage at diagnosis. Treatment of
potentially curative colorectal cancer patients is based on
adequate oncological resection with adjuvant treatment
when indicated.2 The laparoscopic approach is associated
with a faster recovery and shorter hospital stay.5 Laparo-
scopic colorectal surgery for cancer has been proven to be
oncologically safe and has become well accepted as a
good surgical approach in recent years.3,4
However, some patients have to be converted to open
surgery and would not benefit from the laparoscopic
approach. Conversion rate in laparoscopic colorectal
surgery for cancer varies between 10% to 15% at expe-
rienced centers but may increase to 30% in others.4
Reasons for conversion may include anatomical as-
pects, large tumors, adhesions, obesity, and intraoper-
ative complications.6
Converted patients may have prolonged operating time,
increased morbidity, and slower recovery.7,8 Little data are
available with respect to the impact of conversion on the
long-term outcome in patients with CRC. The objective of
this study was to evaluate the impact of conversion on the
perioperative outcome and mainly on long-term disease-
free and overall survival.
PATIENTS AND METHODS
Data included patients operated on laparoscopically from
late 2003 to the beginning of 2009. All operations were
performed or directed by 2 laparoscopically trained sur-
geons with previous training in laparoscopic colorectal
surgery.
Early in the study, the operations were performed by both
surgeons. Later on, the procedures were performed or
directed by either one of these 2 senior surgeons. The
volume of laparoscopic colorectal operations during the
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SCIENTIFIC PAPERstudy period averaged 70 cases a year with about one-half
of them performed for colorectal cancer.
The in-hospital data including all parameters regarding
patient demographics, operative data, hospitalization and
final pathology were collected prospectively and were
inserted into an Excel program file that was specifically
created for this purpose.
Long-term data regarding survival and recurrence was
retrieved from our outpatient follow-up charts. When data
were not available or were not clear, the patients were
personally contacted.
Our routine follow-up protocol for colorectal cancer pa-
tients includes physical examination and CEA blood level
every 3 months in the first year, every 4 months in the
second year, and every 6 months from the third year until
5 years after surgery. Colonoscopy is performed 1 and 3
years after surgery. A CT scan is performed 1 year after
surgery.
Principles of the Surgical Technique
Generally, we adopted a standard surgical approach that
was retained in most cases. For right colectomies, we use
a 3-port technique with a medial to lateral mesocolon
dissection, lateral mobilization, colonic exteriorization,
colonic transection and extracorporal anastomosis. Left-
sided resections are performed with 4-ports with a medial
to lateral dissection, lateral mobilization, intracorporeal
distal transection, exteriorization of the proximal colon
with proximal transection and intracorporal anastomosis
using an endoluminal stapler.
Statistics
Statistical analysis was performed using the chi-square
test, t test, the Mann-Whitney nonparametric test, and
long-rank test for Kaplan-Mayer survival curves. A Cox
regression model was used for multivariate analysis.
P.05 was considered significant.
RESULTS
Surgery was performed in 175 patients for curable CRC
(stage I-III) with at least 1-year follow-up. This group was
further evaluated.
For various reasons, 25 patients (14.4%) had to be con-
verted. Reasons for conversion included large tumors that
were difficult to manipulate laparoscopically (44%), low
rectal tumors difficult to mobilize (12%), severe adhesions
(12%), tumors that were not found laparoscopically (16%),
and other reasons (16%). In only 4 cases (12%) was the
conversion purely a reactive one due to an intraoperative
complication.
A comparison between the converted and laparoscopic
completed groups revealed no significant difference in
disease stage, T stage, BMI, and the rate of previous
abdominal operations. However, there were more rectal
and fewer right colon tumors in the converted group
(Table 1). The proportion of patients with a lower 2/3
rectal tumor scheduled for TME and patients with upper
rectal tumors who underwent wide mesorectal excision
was similar in both groups (one-third of rectal cancer
patients had their tumor in the lower two-thirds of the
rectum in both groups). Only 3 patients (2 from the non-
converted and 1 from the converted group) were referred
for neoadjuvant radiotherapy due to locally advanced
lower two-thirds tumors.
A comparison of the short-term operative outcome re-
vealed a worse perioperative course for the converted
group with increased septic complications and longer
hospital stay (Table 2).
Five-year Kaplan Meier analysis for disease-free survival was
worse for converted patients; however, overall survival did
not differ between the 2 groups (Figures 1 and 2).
Prognosis factors for disease recurrence including conver-
sion, age, sex, tumor location (ie, rectum, left-sided, right-
sided, and transverse) and AJCC staging were introduced
into a Cox proportional analysis to identify the significant
variables. Only conversion (P0.05, HR2.3) and AJCC
stage (stage II P0.01 HR6.0, stage III, P0.008
HR7.4) were found to be independent risk factors for
recurrence.
DISCUSSION
Surgical approach to colorectal pathologies has changed
gradually in the past decade with more surgeons now
performing laparoscopic colorectal surgery. Concerns
over the adequacy of the laparoscopic approach in
colorectal cancer was gradually abandoned leading to
an approved statement by several organizations on the
safety of the laparoscopic approach in colon cancer
patients3,4 and further confirmation by long-term mul-
ticenter studies.9,10
As in other laparoscopic procedures, the laparoscopic
approach for colorectal cancer patients offers short-term
benefits with an earlier return of gastrointestinal function,
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results, and shorter hospital stay.5,11 However, patients
who undergo conversion to open surgery obviously
would not benefit from these potential advantages. De-
spite improved experience and the constant development
of laparoscopic technology, experienced centers still
quote conversion rates of 10% to 15%.6,7 These figures
reflect the limitation of laparoscopy in certain circum-
stances related to patient or disease factors.
Table 1.
Patients and Tumor Characteristics of Converted Versus Laparoscopic-completed Group
Converted Group Nonconverted P Value
(%) (%)
Number of Patients 25 150
Age 74.4  9.9 69.7  12.5 0.076
No. Females 14 (56) 80 (53) 0.76
BMI 26.9  4.0 27.2  4.7 0.8
Previous Abdominal Operations (excluding
inguinal hernias and appendectomies)
7 (28) 34 (24.1) 0.75
Operative Time (min) 172  72.3 145.6  55.6 0.034
Tumor Location
Right colon 8 (32) 73 (49) 0.03
Rectum 9 (36) 21 (14)
Stage Distribution
Stage I 7 (28) 49 (33)
Stage II 7 (28) 55 (37) 0.4
Stage III 11 (44) 46 (30)
T Stage
T1 2 (8) 19 (12)
T2 6 (24) 37 (25) 0.37
T3 15 (60) 91 (61)
T4 2 (8) 3 (2)
Poorly Differentiated Tumors 2 (8) 14 (9.3) NS
Table 2.
Immediate Operative Outcome of Converted Versus
Laparoscopic-completed Group
Converted
Group
Nonconverted P Value
(%) (%)
Number of Patients 25 150
Mortality 1 (4) 0 (0) 0.14
Major Surgical
Complications
5 (20) 9 (6) 0.035
Wound Infection 5 14 0.16
Operative Time 172.9  72.3 145  55.7 0.09
Hospital Stay 14.4  10.0 8.3  7.1 0.0064
Figure 1. Kaplan-Meier analysis for overall survival, converted
versus laparoscopic-completed group.
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obesity, substantial adhesions, inflammatory conditions,
and specifically cancer patients with large tumors and low
rectal tumors.12
In our series, more than half of the patients were con-
verted due to the difficulty of handling large tumors or low
rectal tumors. Substantial data show that converted pa-
tients may experience a worse perioperative outcome
compared with those who have a completed laparoscopy.
Several studies7,8,12 have demonstrated that conversion in
laparoscopic colorectal resection is associated with pro-
longed operative times, increased morbidity reflected in
more anastomotic leaks and wound infections, increased
need for blood transfusion, a slower recovery, and a
longer hospital stay. Our results mimic these findings with
a longer and more complicated postoperative course in
the converted group.
Patients in the converted group had significantly more
major surgical complications (20% versus 6%), a trend
towards more wound infections (although not statistically
significant, 20% vs. 9.4%, P0.12), and a substantially
longer hospital stay that averaged more than 14 days and
was 6 days longer than the laparoscopically completed
group. The reason for the increased complication rate and
slower recovery in our series and in others lies probably in
the fact that conversion is in many cases an indicator of a
more complex and surgically challenging case regardless
of the surgical approach (laparoscopic or open). Other
reasons may be related to the prolonged operative times
and the increased reported blood loss, both of which may
cause an increase in body stress response and dampen the
host immune response leading to increased susceptibility
to developing postoperative complications.13
An interesting study by Belizon et al8 demonstrated that
prompt conversion in 30 minutes may reduce the over-
all morbidity associated with conversion. In addition, a
recent study comparing short-term outcome of converted
cases to primarily open colorectal resection demonstrated
that conversion did not result in poorer short-term out-
comes than the open colorectal resections.14 One of the
limitations of our study is that the timing of conversion
was not recorded, and we could not evaluate the impact
of this factor on patient outcomes.
The second aim of this study was to evaluate the long-
term oncological outcome of cancer patients. The main
limitations of our study in this aspect are the limited
number of patients and follow-up time. However, it is
important to note that we included in this study only
patients who had at least 1-year of follow-up and that
more than half of our patients had at least a 3-year follow-
up. Additionally, this study reflects the experience of a
dedicated laparoscopic colorectal team. Few studies have
looked into this issue.13,15–18 These studies report similar
trends towards worse long-term outcome in converted
patients; however, their results were different regarding
overall and disease-free survival.
Chan et al13 demonstrated no statistically significant dif-
ference in overall survival between laparoscopically com-
pleted and converted patients. However, they did show a
worse 5-year disease-free survival with a significant in-
crease in local recurrence in the converted group.
Comparable results were reported by Ptok et al.15 They,
likewise, demonstrated no difference in 5-year overall
survival, but, interestingly, they reported a worse disease-
free survival only in stage II converted patients. Contrary
to these reports, other studies have demonstrated a worse
overall survival16,17 but no change in disease-free sur-
vival.18
Moloo et al16 demonstrated a worse overall 2-year survival
rate and a trend towards lower 5-year survival for con-
verted patients compared to laparoscopic-completed
ones. However, they did not report on disease-free sur-
vival. The converted and nonconverted groups had simi-
lar stage distribution, and the difference in survival could
not be attributed to cancer stage. Subgroup analysis from
the CLASSIC trial18 revealed that conversion to an open
operation was associated with a significantly worse over-
all but not disease-free survival. This was mostly marked
in the early follow-up period.
Figure 2. Kaplan-Meier analysis for disease free survival, con-
verted versus laparoscopic-completed group
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showed that conversion increased the perioperative mor-
bidity, but, moreover, it had a negative impact on overall
survival.
In our series, the converted patients had a worse disease-
free survival with no impact on overall survival. Because
our follow-up is somewhat limited, it may be assumed that
a difference in overall survival might be evident later in
the follow-up.
It is important to note that converted patients are not a
homogenous group, and the characteristics of converted
patients undergoing laparoscopy for CRC may vary between
different surgeons and centers. Other factors that may impact
the characteristics of a group of converted patients is the
learning curve of the specific surgeon or center and obvi-
ously the different indications for conversion.
In our series, there was no difference in stage distribution
between converted and nonconverted patients; however,
the converted group had had more low rectal tumors that
may be associated with an increased recurrence rate. Rot-
toli et al19 in a recently published article reported a higher
local recurrence rate for converted patients in a series of
173 laparoscopic rectal resections.
Furthermore, also in the Chan et al13 study, it appears that
the difference in disease-free survival between converted
and nonconverted patients lies mainly in the difference in
rectal cancer patients. Nearly all local recurrences in their
series were in patients with rectal cancer with a 9.8% local
recurrence in the converted group versus 2.8% in the
nonconverted group. Nevertheless, in our study conver-
sion was found to be an independent factor for recurrence
in a multivariate analysis.
CONCLUSION
We have demonstrated a decrease in disease-free survival
in converted versus laparoscopic-completed colorectal
cancer patients operated on to cure their condition. These
results are comparable to results of other recent published
reports. However, the exact explanation for this difference
is not very clear.
Reasons for the difference in long-term outcome may be
attributed to the increased complication rate that may
impact the immune system perioperatively and lead to a
higher chance for recurrence. Additionally, it may be re-
lated to some characteristics of converted patients such as
a higher rate of complex rectal cancers. We believe that an
early and correctly judged conversion is important to
avoid a short- and long-term inferior outcome. Late con-
versions, specifically in low and difficult rectal cases, may
lead to inadequate surgery that may put the patient at risk
for postoperative complications and long-term outcome.
Further larger studies with standardization of late versus
early conversion and stratification for tumor stage and
location are needed to draw final conclusions.
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